Surgical management of gastrointestinal stromal tumours

British Journal of Surgery

Volumn 96, Issue 6, 2009, Pages 567-578

  Gervaz, P ^a   Huber, O ^a   Morel, P ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IMATINIB;

CLINICAL FEATURE; COLON TUMOR; DUODENUM TUMOR; ESOPHAGUS TUMOR; GASTRECTOMY; GASTROINTESTINAL CARCINOMA; GASTROINTESTINAL STROMAL TUMOR; HUMAN; LOWER ESOPHAGUS SPHINCTER; LYMPH NODE DISSECTION; METASTASIS; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; RECTUM TUMOR; REVIEW; SMALL INTESTINE TUMOR; STOMACH ANTRUM; STOMACH TUMOR; SURGICAL TECHNIQUE;

ANTINEOPLASTIC AGENTS; DIGESTIVE SYSTEM SURGICAL PROCEDURES; GASTROINTESTINAL STROMAL TUMORS; HUMANS; NEOADJUVANT THERAPY; PIPERAZINES; PYRIMIDINES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 66749133506     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6601     Document Type: Review

References (99)

1. Sleijfer S, Wiemer E, Verweij J. Drug insight: gastrointestinal stromal tumors (GIST) - the solid tumor model for cancer-specific treatment. Nat Clin Pract Oncol 2008; 5: 102-111.
2. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279: 577-580. (Pubitemid 28067289)
3. Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003; 299: 708-710. (Pubitemid 36159485)
4. Kindblom LG, Remotti HE, Aldenborg F, Meis-Kindblom JM. Gastrointestinal pacemaker cell tumor (GIPACT). Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 1998; 152: 1259-1269. (Pubitemid 28221878)
5. Sircar K, Hewlett BR, Huizinga JD, Chorneyko K, Berezin I, Riddell RH. Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors. Am J Surg Pathol 1999; 23: 377-389. (Pubitemid 29159998)
6. Miettinen M, Lasota J. Gastrointestinal stromal tumors - definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 2001; 438: 1-12. (Pubitemid 32128184)
7. Joensuu H, Roberts PJ, Sarlomo-Rikala M, Andersson LC, Tervahartiala P, Tuveson D et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 2001; 344: 1052-1056. (Pubitemid 32267975)
8. Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl JMed 2002; 347: 472-480. (Pubitemid 34879334)
9. Gold JS, DeMatteo RP. Combined surgical and molecular therapy. The gastrointestinal stromal tumor model. Ann Surg 2006; 244: 176-184. (Pubitemid 44305531)
10. Fletcher CDM, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 2002; 33: 459-465. (Pubitemid 34747864)
11. Tran T, Davila JA, El-Serag HB. The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1458 cases from 1992 to 2000. Am J Gastroenterol 2005; 100: 162-168.
12. Nilsson B, Bümming P, Meis-Kindblom JM, Oden A, Dortok A, Gustavsson B et al. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course and prognostication in the preimatinib mesylate era. Cancer 2005; 103: 821-829.
13. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000; 231: 51-58. (Pubitemid 30043939)
14. Joensuu H, Fletcher C, Dimitrijevic S, Silberman S, Roberts P, Demetri G. Management of malignant gastrointestinal stromal tumours. Lancet Oncol 2002; 3: 655-664. (Pubitemid 35314908)
15. Miettinen M, Sarlomo-Rikala M, Sobin LH, Lasota J. Esophageal stromal tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas. Am J Surg Pathol 2000; 24: 211-222. (Pubitemid 30078710)
16. Zhu X, Zhang XQ, Li BM, Xu P, Zhang KH, Chen J. Esophageal mesenchymal tumors: endoscopy, pathology and immunohistochemistry. World J Gastroenterol 2007; 13: 768-773. (Pubitemid 46252399)
17. Bonavina L, Segalin A, Rosati R, Pavanello M, Peracchia A. Surgical therapy of esophageal leiomyoma. J Am Coll Surg 1995; 181: 257-262.
18. Blum MG, Bilimoria KY, Wayne JD, de Hoyos AL, Talamonti MS, Adley B. Surgical considerations for the management and resection of esophageal gastrointestinal stromal tumors. Ann Thorac Surg 2007; 84: 1717-1723. (Pubitemid 47588124)
19. Gouveia AM, Pimenta AP, Lopes JM, Capelinha AF, Ferreira SS, Valbuena C et al. Esophageal GIST: therapeutic implications of an uncommon presentation of a rare tumor. Dis Esophagus 2005; 18: 70-73. (Pubitemid 40542801)
20. Staiger WI, Ronellenfitsch U, Kaehler G, Schildhaus HU, Dimitrakopoulou-Strauss A, Schwarzbach MHM et al. The Merendino procedure following preoperative imatinib mesylate for locally advanced gastrointestinal stromal tumor of the esophagogastric junction. World J Surg Oncol 2008; 6: 37.
21. Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistological, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 2005; 29: 52-68. (Pubitemid 40023952)
22. Heinrich MC, Corless CL. Gastric GI stromal tumors (GISTs): the role of surgery in the era of targeted therapy. J Surg Oncol 2005; 90: 195-207. (Pubitemid 40741187)
23. Novitsky YW, Kercher KW, Sing RF, Heniford BT. Long-term outcomes of laparoscopic resection of gastric gastrointestinal stromal tumors. Ann Surg 2006; 243: 738-747. (Pubitemid 44297474)
24. Huguet KL, Rush RM Jr, Tessier DJ, Schlinkert RT, Hinder RA, Grinberg GG et al. Laparoscopic gastric gastrointestinal stromal tumor resection: the Mayo Clinic experience. Arch Surg 2008; 143: 587-590.
25. Lai IR, Lee WJ, Yu SC. Minimally invasive surgery for gastric stromal cell tumors: intermediate follow-up results. J Gastrointest Surg 2006; 10: 563-566.
26. Choi SM, Kim MC, Jung GJ, Kim HH, Kwon HC, Choi SR et al. Laparoscopic wedge resection for gastric GIST: long-term follow-up results. Eur J Surg Oncol 2007; 33: 444-447. (Pubitemid 46586101)
27. Blay JY, Bonvalot S, Casali P, Choi H, Debiec-Richter M, Dei Tos AP et al. Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. Ann Oncol 2005; 16: 566-578.
28. Demetri GD, Benjamin RS, Blanke CD, Blay JY, Casali P, Choi H et al. NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST) - update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw 2007; 5(Suppl 2): S1-S29. (Pubitemid 47067464)
29. Hiki N, Yamamoto Y, Fukunaga T, Yamaguchi T, Nunobe S, Tokunaga M et al. Laparoscopic and endoscopic cooperative surgery for gastrointestinal stromal tumor dissection. Surg Endosc 2008; 22: 1729-1735.
30. Wilhelm D, von Delius S, Burian M, Schneider A, Frimberger E, Meining A et al. Simultaneous use of laparoscopy and endoscopy for minimally invasive resection of gastric subepithelial masses - analysis of 93 interventions. World J Surg 2008; 32: 1021-1028.
31. Otani Y, Kitajima M. Laparoscopic surgery for GIST: too soon to decide. Gastric Cancer 2005; 8: 135-136. (Pubitemid 41176090)
32. Nishimura J, Nakajima K, Omori T, Takahashi T, Nishitani A, Ito T et al. Surgical strategy for gastric gastrointestinal stromal tumors: laparoscopic vs. open resection. Surg Endosc 2007; 21: 875-878. (Pubitemid 47055768)
33. Davies AR, Ahmed W, Purkiss SF. Port site metastasis following diagnostic laparoscopy for a malignant gastro-intestinal stromal tumor. World J Surg Oncol 2008; 6: 55.
34. Cunningham SC, Shibata D, Volpe C. Isolated abdominal wound metastases from a gastrointestinal stromal tumor. Int J Gastrointest Cancer 2003; 33: 129-132. (Pubitemid 37553344)
35. Privette A, McCahill L, Borrazzo E, Single RM, Zubarik R. Laparoscopic approaches to resection of suspected gastric gastrointestinal stromal tumors based on tumor location. Surg Endosc 2008; 22: 487-494.
36. An JY, Choi MG, Noh JH, Sohn TS, Kang WK, Park CK, et al. Gastric GIST: a single institutional retrospective experience with surgical treatment for primary disease. Eur J Surg Oncol 2007; 33: 1030-1035.
37. Song KY, Kim SN, Park CH. Tailored-approach of laparoscopic wedge resection for treatment of submucosal tumor near the esophagogastric junction. Surg Endosc 2007; 21: 2272-2276. (Pubitemid 350125957)
38. Bédard EL, Mamazza J, Schlachta CM, Poulin EC. Laparoscopic resection of gastrointestinal stromal tumors: not all tumors are created equal. Surg Endosc 2006; 20: 500-503. (Pubitemid 43260515)
39. Sexton JA, Pierce RA, Halpin VJ, Eagon JC, Hawkins WG, Linehan DC et al. Laparoscopic gastric resection for gastrointestinal stromal tumors. Surg Endosc 2008; 22: 2583-2587.
40. Nguyen SQ, Divino CM, Wang JL, Dikman SH. Laparoscopic management of gastrointestinal stromal tumors. Surg Endosc 2006; 20: 713-716. (Pubitemid 43978765)
41. Matsui H, Uyama I, Fujita J, Komori Y, Sugioka A, Hasumi A. Gastrointestinal stromal tumor of the stomach successfully treated by laparoscopic proximal gastrectomy with jejunal interposition. Surg Laparosc Endosc Percutan Tech 2000; 10: 239-242. (Pubitemid 30641421)
42. Tagaya N, Mikami H, Kogure H, Kubota K, Hosoya Y, Nagai H. Laparoscopic intragastric stapled resection of gastric submucosal tumors located near the esophagogastric junction. Surg Endosc 2002; 16: 177-179.
43. Walsh RM, Ponsky J, Brodsy F, Matthews BD, Heniford BT. Combined endoscopic/laparoscopic intragastric resection of gastric stromal tumors. J Gastrointest Surg 2003; 7: 386-392. (Pubitemid 36875777)
44. Fujimoto Y, Nakanishi Y, Yoshimura K, Shimoda T. Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients. Gastric Cancer 2003; 6: 39-48. (Pubitemid 36460555)
45. Hassan I, You YN, Shyyan R, Dozois EJ, Smyrk TC, Okuno SH et al. Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis. Ann Surg Oncol 2008; 15: 52-59.
46. Langer C, Gunawan B, Schüler P, Huber W, Fuzesi L, Becker H. Prognostic factors influencing surgical management and outcome of gastrointestinal stromal tumours. Br J Surg 2003; 90: 332-339. (Pubitemid 36324113)
47. Hsu KH, Yang TM, Shan YS, Lin PW. Tumor size is a major determinant of recurrence in patients with resectable gastrointestinal stromal tumor. Am J Surg 2007; 194: 148-152. (Pubitemid 47008978)
48. Bucher P, Egger JF, Gervaz P, Ris F, Weintraub D, Villiger P et al. An audit of surgical management of gastrointestinal stromal tumours (GIST). Eur J Surg Oncol 2006; 32: 310-314.
49. Miettinen M, Kopczynski J, Makhlouf HR, Sarlomo-Rikala M, Gyorffy H, Burke A et al. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: a clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases. Am J Surg Pathol 2003; 27: 625-641. (Pubitemid 36514473)
50. Lanuke K, Bathe OF, Mack LA. Local excision of duodenal gastrointestinal stromal tumor. J Surg Oncol 2007; 95: 267-269. (Pubitemid 46310021)
51. Takeda A, Watanabe Y, Uehara T, Maruyama T, Tanaka H, Matsuzaki S et al. Successful surgical resection of a huge gastrointestinal stromal tumor of the third portion of the duodenum. J Gastroenterol Hepatol 2007; 22: 283-284. (Pubitemid 46181367)
52. Kwon SH, Cha HJ, Jung SW, Kim BC, Park JS, Jeong ID et al. A gastrointestinal stromal tumor of the duodenum masquerading as a pancreatic head tumor. World J Gastroenterol 2007; 13: 3396-3399. (Pubitemid 47062255)
53. Cavallini M, Cecera A, Ciardi A, Caterino S, Ziparo V. Small periampullary duodenal gastrointestinal stromal tumor treated by local excision: report of a case. Tumori 2005; 91: 264-266. (Pubitemid 41076135)
54. Winfield RD, Hochwald SN, Vogel SB, Hemming AW, Liu C, Cance WG et al. Presentation and management of gastrointestinal stromal tumors of the duodenum. Am Surg 2006; 72: 719-723.
55. Goh BK, Chow PK, Kesavan S, Yap WM, Wong WK. Outcome after surgical treatment of suspected gastrointestinal stromal tumors involving the duodenum: is limited resection appropriate? J Surg Oncol 2008; 97: 388-391.
56. Goh BK, Chow PK, Ong HS, Wong WK. Gastrointestinal stromal tumor involving the second and third portion of the duodenum: treatment by partial duodenectomy and Roux-en-Y duodenojejunostomy. J Surg Oncol 2005; 91: 273-275. (Pubitemid 41266827)
57. Asakawa M, Sakamoto Y, Kajiwara T, Nara S, Esaki M, Shimada K et al. Simple segmental resection of the second portion of the duodenum for the treatment of gastrointestinal stromal tumors. Langenbecks Arch Surg 2008; 393: 605-609.
58. Emory TS, Sobin LH, Lukes L, Lee DH, O'Leary TJ. Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site. Am J Surg Pathol 1999; 23: 82-87. (Pubitemid 29025244)
59. Miettinen M, Makhlouf H, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am J Surg Pathol 2006; 30: 477-489. (Pubitemid 43740149)
60. DeMatteo RP, Gold JS, Saran L, Gönen M, Liau KH, Maki RG et al. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST). Cancer 2008; 112: 608-615.
61. Martín J, Poveda A, Llombart-Bosch A, Ramos R, López-Guerrero JA, García del Muro J et al. Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS). J Clin Oncol 2005; 23: 6190-6198. (Pubitemid 46300238)
62. Keun Park C, Lee EJ, Kim M, Lim HY, Choi DI, Noh JH et al. Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy. Ann Surg 2008; 247: 1011-1018.
63. Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol 2006; 23: 70-83. (Pubitemid 44692418)
64. Crosby JA, Catton CN, Davis A, Couture J, O'Sullivan B, Kandel R et al. Malignant gastrointestinal stromal tumors of the small intestine: a review of 50 cases from a prospective database. Ann Surg Oncol 2001; 8: 50-59. (Pubitemid 32140424)
65. Wu TJ, Lee LY, Yeh CN, Wu PY, Chao TC, Hwang TL et al. Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate. BMC Gastroenterology 2006; 6: 29.
66. Rondonotti E, Pennazio M, Toth E, Menchen P, Riccioni ME, De Palma GD et al. Small-bowel neoplasms in patients undergoing video capsule endoscopy: a multicenter European study. Endoscopy 2008; 40: 488-495.
67. Chong AK, Chin BW, Meredith CG. Clinically significant small-bowel pathology identified by double-balloon enteroscopy but missed by capsule endoscopy. Gastrointest Endosc 2006; 64: 445-449. (Pubitemid 44233581)
68. Ross A, Mehdizadeh S, Tokar J, Leighton JA, Kamal A, Chen A et al. Double balloon enteroscopy detects small bowel mass lesions missed by capsule endoscopy. Dig Dis Sci 2008; 53: 2140-2143.
69. Lin MB, Yin L, Li JW, Hu WG, Qian QJ. Double-balloon enteroscopy reliably directs surgical intervention for patients with small intestinal bleeding. World J Gastroenterol 2008; 14: 1936-1940.
70. Almeida N, Figueiredo P, Lopes S, Gouveia H, Leitão MC. Double-balloon enteroscopy and small bowel tumors: a South-European single-center experience. Dig Dis Sci 2008 [Epub ahead of print].
71. Yeh TS, Liu KH, Su MY, Lin CH, Chiu CT, Tseng JH. Laparoscopically assisted bowel surgery in an era of double-balloon enteroscopy: from inside to outside. Surg Endosc 2009; 23: 739-744.
72. Miettinen M, Sarlomo-Rikala M, Sobin LH, Lasota J. Gastrointestinal stromal tumors and leiomyosarcomas in the colon: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases. Am J Surg Pathol 2000; 24: 1339-1352.
73. Miettinen M, Sarlomo-Rikala M, Sobin LH. Mesenchymal tumors of muscularis mucosae of colon and rectum are benign leiomyomas that should be separated from gastrointestinal stromal tumors - a clinicopathologic and immunohistochemical study of eighty-eight cases. Mod Pathol 2001; 14: 950-956. (Pubitemid 32976781)
74. Hassan I, You YN, Dozois EJ, Shayyan R, Smyrk TC, Okuno SH et al. Clinical, pathologic, and immunohistochemical characteristics of gastrointestinal stromal tumors of the colon and rectum: implications for surgical management and adjuvant therapies. Dis Colon Rectum 2006; 49: 609-615. (Pubitemid 43723808)
75. Chen CW, Wu CC, Hsiao CW, Fang FC, Lee TY, Che FC et al. Surgical management and clinical outcome of gastrointestinal stromal tumors of the colon and rectum. Z Gastroenterol 2008; 46: 760-765.
76. Miettinen M, Furlong M, Sarlomo-Rikala M, Burke A, Sobin LH, Lasota J. Gastrointestinal stromal tumors, intramural leiomymomas, and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases. Am J Surg Pathol 2001; 25: 1121-1133. (Pubitemid 32777711)
77. Baik SH, Kim NK, Lee CH, Lee KY, Sohn SK, Cho CH et al. Gastrointestinal stromal tumor of the rectum: an analysis of seven cases. Surg Today 2007; 37: 455-459. (Pubitemid 46828752)
78. Testroote M, Hoornweg M, Rhemrev S. Rectal GIST presenting as a submucosal calculus. Dig Dis Sci 2007; 52: 1047-1049. (Pubitemid 46481237)
79. Matsushima K, Kayo M. Transsacral approach to resect a gastrointestinal stromal tumor in the rectum: report of two cases. Surg Today 2007; 37: 698-701. (Pubitemid 47101253)
80. Gervaz P, Huber O, Bucher P, Sappino P, Morel P. Trans-sacral (Kraske) approach for gastrointestinal stromal tumour of the lower rectum: old procedure for a new disease. Colorectal Dis 2008; 10: 951-952.
81. Hellan M, Maker VK. Transvaginal excision of a large rectal stromal tumor: an alternative. Am J Surg 2006; 191: 121-123. (Pubitemid 43042534)
82. Dickson BC, Srigley JR, Pollett AF, Blackstein ME, Honey JD, Juco JW. Rectal gastrointestinal stromal tumor mimicking a primary prostatic lesion. Can J Urol 2008; 15: 4112-4114.
83. Ghobadi A, Kabbani W, Barker B, Dowell JE. Rectal GI stromal tumor mimicking a prostate mass. J Clin Oncol 2007; 25: 5827-5828.
84. Herawi M, Montgomery EA, Epstein JI. Gastrointestinal stromal tumors (GISTs) on prostate needle biopsy: a clinicopathologic study of 8 cases. Am J Surg Pathol 2006; 30: 1389-1395. (Pubitemid 44655472)
85. Gold JS, van der Zwan SM, Gönen M, Maki RG, Singer S, Brennan MF et al. Outcome of metastatic GIST in the era before tyrosine kinase inhibitors. Ann Surg Oncol 2007; 14: 134-142. (Pubitemid 44954280)
86. Mudan SS, Conlon KC, Woodruff JM, Lewis JJ, Brennan MF. Salvage surgery for patients with recurrent gastrointestinal sarcoma: prognostic factors to guide patient selection. Cancer 2000; 88: 66-74. (Pubitemid 30027680)
87. Eisenberg BL, Judson I. Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy. Ann Surg Oncol 2004; 11: 465-475. (Pubitemid 40486727)
88. Gronchi A, Fiore M, Miselli F, Lagonigro MS, Coco P, Messina A et al. Surgery of residual disease following molecular-targeted therapy with imatinib mesylate in advanced/metastatic GIST. Ann Surg 2007; 245: 341-346. (Pubitemid 46673127)
89. DeMatteo RP, Maki RG, Singer S, Gonen M, Brennan MF, Antonescu CR. Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor. Ann Surg 2007; 245: 347-352. (Pubitemid 46673128)
90. Raut CP, Posner M, Desai J, Morgan JA, George S, Zahrieh D et al. Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors. J Clin Oncol 2006; 24: 2325-2331. (Pubitemid 46630664)
91. Bauer S, Hartmann JT, de Wit M, Lang H, Grabellus F, Antoch G et al. Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib. Int J Cancer 2005; 117: 316-325. (Pubitemid 41377453)
92. Connolly EM, Gaffney E, Reynolds JV. Gastrointestinal stromal tumors. Br J Surg 2003; 90: 1178-1186.
93. Antonescu CR, Sommer G, Sarran L, Tschernyavsky SJ, Riedel E, Woodruff JM et al. Association of KIT exon 9 mutation with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors. Clin Cancer Res 2003; 9: 3329-3337. (Pubitemid 37082727)
94. Heinrich MC, Corless CL, Demetri GD, Blanke CD, von Mehren M, Joensuu H et al. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 2003; 21: 4342-4349. (Pubitemid 46621810)
95. Gomes AL, Bardales RH, Milanezi F, Reis RM, Schmitt F. Molecular analysis of c-Kit and PDGFRA in GISTs diagnosed by EUS. Am J Clin Pathol 2007; 127: 89-96. (Pubitemid 46797023)
96. Alberini JL, Al Nakib M, Wartski M, Gontier E, Cvitkovic F, Rixe O et al. The role of PET scan in gastrointestinal stromal tumors. Gastroenterol Clin Biol 2007; 31: 585-593. (Pubitemid 47094597)
97. Haller F, Detken S, Schulten HJ, Happel N, Gunawan B, Kuhlgatz J et al. Surgical management after neoadjuvant imatinib therapy in gastrointestinal stromal tumours (GISTs) with respect to imatinib resistance caused by secondary KIT mutations. Ann Surg Oncol 2007; 14: 526-532. (Pubitemid 46175297)
98. Andtbacka RH, Ng CS, Scaife CL, Cormier JN, Hunt KK, Pisters PWet al. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib. Ann Surg Oncol 2007; 14: 14-24. (Pubitemid 44954266)
99. Eisenberg BL, Harris J, Blanke CD, Demetri GD, Heinrich MC, Watson JC et al. Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): early results of RTOG 0132/ACRIN 6665. J Surg Oncol 2008; 99: 42-47.